Enhanced proliferation and decreased apoptosis in lung lavage cells of sarcoidosis patients

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 23, Issue 3, 2006, Pages 190-200

  Petzmann, Susanna ^a   Maercker, Christian ^b,c   Markert, Eva ^a   Kern, Izidor ^d   Osolnik, Katharina ^d   Pohl, Wolfgang ^e   Popper, Helmut H ^a,f  

^a RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF APPLIED SCIENCES   (Germany)

^d UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^e Pulmonary Hospital   (Austria)

^f UNIVERSITY OF GRAZ   (Austria)

Author keywords

Apoptosis; Gene profiling; L fgren's disease; Proliferation; Sarcoidosis

Indexed keywords

COMPLEMENTARY DNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DNA MICROARRAY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENOME ANALYSIS; HELPER CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG LAVAGE; LUNG SARCOIDOSIS; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE SECTION; TRANSCRIPTION INITIATION; UNINDEXED SEQUENCE; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ACUTE DISEASE; ADULT; APOPTOSIS; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CELL PROLIFERATION; CHRONIC DISEASE; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MACROPHAGE ACTIVATION; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS C-AKT; SARCOIDOSIS, PULMONARY; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 35348981224     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ebe Y, Ikushima S, Yamaguchi T, et al: Proliferative response of peripheral blood mononuclear cells and levels of antibody to recombinant protein from Propionibacterium acnes DNA expression library in Japanese patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17: 256-65.
2. Popper HH, Klemen H, Hoefler Gand Winter E: Presence of mycobacterial DNA in sarcoidosis. Hum Pathol 1997; 28: 796-800.
3. Elford J, Fitch P, Kaminski E, McGavin Cand Wells IP: Five cases of sarcoidosis in one family: a new immunological link? Thorax 2000; 55: 343-4.
4. Mana J, Badrinas F, Morera J, Fite E, Manresa Fand Fernandez-Nogues F: Sarcoidosis in Spain. Sarcoidosis 1992; 9: 118-22.
5. Rybicki BA, Maliarik MJ, Major M, Popovich J Jr, Iannuzzi MC: Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect 1998; 13: 166-73.
6. Amoli MM, Thomson W, Hajeer AH, et al: HLA-DRB1 associations in biopsy proven erythema nodosum. J Rheumatol 2001; 28: 2660-2.
7. Bogunia-Kubik K, Tomeczko J, Suchnicki Kand Lange A: HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens 2001; 57: 87-90.
8. Foley P, Lympany P, Puscinska E, et al: HLA-DPB1 and TAP1 polymorphisms in sarcoidosis. Chest 1997; 111: 73S.
9. Foley PJ, McGrath DS, Puscinska E, et al: Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am J Respir Cell Mol Biol 2001; 25: 272-7.
10. Grunewald J, Eklund Aand Olerup O: Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 2004; 169: 696-702.
11. Lympany PA, Petrek M, Southcott AM, Newman Taylor AJ, Welsh KIand du Bois RM: HLA-DPB polymorphisms: Glu 69 association with sarcoidosis. Eur J Immunogenet 1996; 23: 353-9.
12. Mrazek F, Holla LI, Hutyrova B, et al: Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren's syndrome in Czech patients with sarcoidosis. Tissue Antigens 2005; 65: 163-71.
13. Naruse TK, Matsuzawa Y, Ota M, et al: HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis. Tissue Antigens 2000; 56: 52-7.
14. Sato H, Grutters JC, Pantelidis P, et al: HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 2002; 27: 406-12.
15. Schurmann M, Reichel P, Muller-Myhsok B, Schlaak M, Muller-Quernheim Jand Schwinger E: Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001; 164: 840-6.
16. Rybicki BA, Walewski JL, Maliarik MJ, Kian Hand Iannuzzi MC: The BTNL2 Gene and Sarcoidosis Susceptibility in African Americans and Whites. Am J Hum Genet 2005; 77: 491-9.
17. Valentonyte R, Hampe J, Huse K, et al: Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005; 37: 357-64.
18. Thonhofer R, Maercker Cand Popper HH: Expression of sarcoidosis related genes in lung lavage cells. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 59-65.
19. Rutherford RM, Kehren J, Staedtler F, et al: Functional genomics in sarcoidosis - reduced or increased apoptosis? Swiss Med Wkly 2001; 131: 459-70.
20. Costabel Uand Hunninghake GW: ATS/ERS/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders. Eur Respir J 1999; 14: 735-7.
21. Boer JM, Huber WK, Sultmann H, et al: Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res 2001; 11: 1861-70.
22. Nakatani K, Thompson DA, Barthel A, et al: Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. J Biol Chem 1999; 274: 21528-32.
23. Fisher GM, Iqball Sand Knight SC: Gene expression during differentiation of human dendritic cells from cord blood cd34 stem cells. Cytokine 1999; 11: 111-7.
24. Llaverias G, Noe V, Penuelas S, et al: Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages. Biochem Biophys Res Commun 2004; 318: 265-74.
25. De Vos J, Couderc G, Tarte K, et al: Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays. Blood 2001; 98: 771-80.
26. Chen GG, Lai PB, Chan PK, et al: Decreased expression of Bid in human hepatocellular carcinoma is related to hepatitis B virus X protein. Eur J Cancer 2001; 37: 1695-702.
27. Bruyns E, Marie-Cardine A, Kirchgessner H, et al: T cell receptor (TCR) interacting molecule (TRIM), a novel disulfide-linked dimer associated with the TCR-CD3-zeta complex, recruits intracellular signaling proteins to the plasma membrane. J Exp Med 1998; 188: 561-75.
28. Gelkop S, Babichev Yand Isakov N: T cell activation induces direct binding of the Crk adapter protein to the regulatory subunit of phosphatidylinositol 3-kinase (p85) via a complex mechanism involving the Cbl protein. J Biol Chem 2001; 276: 36174-82.
29. Qing Yand Stark GR: Alternative activation of STAT1 and STAT3 in response to interferon-gamma. J Biol Chem 2004; 27: 27.
30. Eves EM, Xiong W, Bellacosa A, et al: Akt, a target of phosphatidylinositol 3-kinase, inhibits apoptosis in a differentiating neuronal cell line. Mol Cell Biol 1998; 18: 2143-52.
31. Currie RA, Walker KS, Gray A, et al: Role of phosphatidylinositol 3,4,5-trisphosphate in regulating the activity and localization of 3-phosphoinositide-dependent protein kinase-1. Biochem J 1999; 337: 575-83.
32. Lawlor MAand Alessi DR: PKB/Akt: a key mediator of cell proliferation, survival and insulin responses? J Cell Sci 2001; 114: 2903-10.
33. Asnaghi L, Bruno P, Priulla Mand Nicolin A: mTOR: a protein kinase switching between life and death. Pharmacol Res 2004; 50: 545-9.
34. Yonezawa K, Yoshino KI, Tokunaga Cand Hara K: Kinase activities associated with mTOR. Curr Top Microbiol Immunol 2004; 279: 271-82.
35. Guschin D, Rogers N, Briscoe J, et al: A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. Embo J 1995; 14: 1421-9.
36. Takeda K, Kaisho T, Yoshida N, Takeda J, Kishimoto Tand Akira S: Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. J Immunol 1998; 161: 4652-60.
37. Suzuki A, Yamaguchi MT, Ohteki T, et al: T cell-specific loss of Pten leads to defects in central and peripheral tolerance. Immunity 2001; 14: 523-34.
38. Tan NS, Shaw NS, Vinckenbosch N, et al: Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol 2002; 22: 5114-27.
39. Duplus Eand Forest C: Is there a single mechanism for fatty acid regulation of gene transcription? Biochem Pharmacol 2002; 64: 893-901.
40. Li H, Zhu H, Xu CJand Yuan J: Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998; 94: 491-501.
41. Rosenquist M: 14-3-3 proteins in apoptosis. Braz J Med Biol Res 2003; 36: 403-8.
42. Thorne Mand Tschopp J: Regulation of lymphocyte proliferation and death by FLIP. Nat Rev Immunol 2001; 1: 50-8.
43. Hunninghake GWand Crystal RG: Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N Engl J Med 1981; 305: 429-34.
44. Agostini C, Semenzato Gand James DG: Immunological, clinical and molecular aspects of sarcoidosis. Mol Aspects Med 1997; 18: 91-165.